| Abiraterone studied in …STUDIED_INderived111 of 111show fewer |
|---|
| → studied in | NCT07190300Phase 1/Phase 2 · recruiting TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) · 111 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07226986Phase 1/Phase 2 · recruiting A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC · 111 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03431350Phase 2 · active not recruiting A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer · 111 trials list this drug (47 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04497844Phase 3 · active not recruiting A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-MutatedProstatic Neoplasms (mCSPC) · 111 trials list this drug (47 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04577833Phase 1 · active not recruiting A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancer · 111 trials list this drug (47 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07570979Phase 1 · recruiting A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer · 111 trials list this drug (47 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06991556Phase 2 · active not recruiting An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC) · 111 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06863272Phase 1/Phase 2 · recruiting A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02) · 111 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05751941Phase 2 · active not recruiting Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06764485Phase 3 · active not recruiting A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer · 111 trials list this drug (47 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07287150Phase 2 · recruiting A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer · 111 trials list this drug (47 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07802704Phase 3 · not yet recruiting A Study of Risvutatug Rezetecan in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) · 111 trials list this drug (47 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05942001Phase 1 · recruiting Study of HRS-5041 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04631601Phase 1/Phase 2 · terminated Safety and Efficacy of Therapies for Metastatic Castration-resistant Prostate Cancer (mCRPC) · 111 trials list this drug (47 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07611110Phase 3 · recruiting AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01) · 111 trials list this drug (47 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04221542Phase 1 · recruiting Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07237269Phase 2 · recruiting Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05067140Phase 1/Phase 2 · active not recruiting A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer · 111 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07620574Phase 3 · enrolling by invitation Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study · 111 trials list this drug (47 active) | — | — | Malignant Neoplasm,Hepatocellular Carcinoma,Pancreatic Neuroendocrine Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04812366Phase 2 · recruiting Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05404139Phase 2 · recruiting Duration of Androgen Receptor Pathway Inhibitor and ADT With Metastasis Directed Therapy in Oligometastatic Cancer of the Prostate (DIRECT) · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07641855Phase 2/Phase 3 · not yet recruiting A Study of BL-B01D1 Combination Therapy in Patients With Metastatic Castration-resistant Prostate Cancer · 111 trials list this drug (47 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07721532active not recruiting Observing the Real-world Non-interventional Study of Abiraterone Acetate Tablets (II) in Treating Chinese Patients With Metastatic Prostate Cancer · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06520345Phase 3 · recruiting The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global) · 111 trials list this drug (47 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06378866Phase 2 · recruiting Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm,Castration-Resistant Prostate Carcinoma,Castration-Sensitive Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07711002Phase 3 · not yet recruiting Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05) · 111 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06592924Phase 3 · recruiting Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02861573Phase 1/Phase 2 · active not recruiting Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) · 111 trials list this drug (47 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04748042Phase 2 · active not recruiting Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON) · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04175431Phase 2 · recruiting Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study · 111 trials list this drug (47 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07140900Phase 1 · recruiting Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer · 111 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05288166Phase 3 · active not recruiting A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer) · 111 trials list this drug (47 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06220864Phase 1 · recruiting SNV1521 in Participants With Advanced Solid Tumors · 111 trials list this drug (47 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03934840Phase 2 · completed CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03860987Phase 2 · completed Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer · 111 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06691984Phase 3 · active not recruiting Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute) · 111 trials list this drug (47 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04262154Phase 2 · active not recruiting Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05177042Phase 1 · completed Trial of ARV-110 and Abiraterone in Participants With Metastatic Prostate Cancer · 111 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07553988Phase 2 · active not recruiting A Comparative Dose-finding Study of RS-113 in Patients With Metastatic Castration-resistant Prostate Cancer · 111 trials list this drug (47 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05588609Phase 2 · terminated Study Evaluating Zenocutuzumab in Patients With or Without Molecularly Defined Cancers · 111 trials list this drug (47 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02772588Phase 2 · completed AASUR in High Risk Prostate Cancer · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06173362Phase 2 · recruiting Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancer · 111 trials list this drug (47 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07230106Phase 2 · recruiting A Study of SHR3680, HS-20093 and SHR2554 in Subjects With Prostate Cancer · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05551117Phase 2 · terminated A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors · 111 trials list this drug (47 active) | — | — | Carcinoma,Melanoma,Non-Small Cell Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05701007completed Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland · 111 trials list this drug (47 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02125617terminated Urokinase Plasminogen Activator Receptor in Abiraterone Treated Patients With Castration Resistant Prostate Cancer · 111 trials list this drug (47 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04647526Phase 3 · active not recruiting Study Evaluating mCRPC Treatment Using PSMA [Lu-177]-PNT2002 Therapy After Second-line Hormonal Treatment · 111 trials list this drug (47 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01995058Phase 2 · terminated Combo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPC · 111 trials list this drug (47 active) | — | — | Prostate Neoplasm,Malignant Prostate Neoplasm,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04034095completed A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan · 111 trials list this drug (47 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03511196early Phase 1 · active not recruiting Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer · 111 trials list this drug (47 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01961843NA · completed Abiraterone Acetate for Castrate Resistant Prostate Cancer · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05914116Phase 1/Phase 2 · recruiting A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors · 111 trials list this drug (47 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03480646Phase 1/Phase 2 · completed ProSTAR: A Study Evaluating CPI-1205 in Patients With Metastatic Castration Resistant Prostate Cancer · 111 trials list this drug (47 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06060587Phase 2 · withdrawn Randomized Phase II Study of ADT + Abiraterone vs ADT + Docetaxel + Abiraterone · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02711137Phase 1/Phase 2 · terminated Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies · 111 trials list this drug (47 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05276492Phase 1 · terminated Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose. · 111 trials list this drug (47 active) | — | — | Prostate Adenocarcinoma,Prostate Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05733351Phase 1 · terminated Vudalimab (XmAb20717) in Combination With Standard of Care Treatment in Patients With Metastatic Castration Sensitive Prostate Cancer · 111 trials list this drug (47 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Castration-Sensitive Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03678025Phase 3 · recruiting Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03458247Phase 2 · completed Study of Dose Escalation of Abiraterone Actetate in Prostate Cancer · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06689163Phase 1/Phase 2 · recruiting A Study for the Treatment of Metastatic Prostate Cancer With HRS-1167 Tablets Combined With Abiraterone Acetate Tablets and Prednisone · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04666129Phase 1 · completed Study of Relugolix in Men With Metastatic Castration-Sensitive Prostate Cancer or Non-Metastatic or Metastatic Castration-Resistant Prostate Cancer · 111 trials list this drug (47 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03298087Phase 2 · completed Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer · 111 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03072238Phase 3 · completed Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07001709Phase 4 · recruiting Determining the Effect of Abiraterone on the Metabolism of Oxycodone in Men With Prostate Cancer (the ENABLE Study) · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03903835Phase 3 · recruiting ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer · 111 trials list this drug (47 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02043678Phase 3 · completed Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild Symptoms · 111 trials list this drug (47 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02366494completed Micro RNAs to Predict Response to Androgen Deprivation Therapy · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03414034Phase 2 · completed Onvansertib in Combination With Abiraterone and Prednisone in Adult Patients With Metastatic Castration-Resistant Prostate Cancer · 111 trials list this drug (47 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04207255Phase 2 · completed Addition of Opaganib to Androgen Antagonists in Patients With mCRPC · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05084859Phase 1 · terminated A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors · 111 trials list this drug (47 active) | — | — | Lung Non-Small Cell Carcinoma,Malignant Colorectal Neoplasm,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06500247Phase 2 · not yet recruiting Darxicilib Combined With Abiraterone Acetate Tablets (II) for the Treatment of Advanced Metastatic Castration-resistant Prostate Cancer. · 111 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06473259recruiting Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients · 111 trials list this drug (47 active) | — | — | Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03141671Phase 2 · unknown Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone and Apalutamide for Rising PSA After RP (FORMULA-509) · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04726332Phase 1 · terminated Study of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (QUARTZ-101) · 111 trials list this drug (47 active) | — | — | Malignant Neoplasm,Ovarian Carcinoma,Hormone Receptor-Positive Breast Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05361915Phase 2 · suspended Study to Assess Abivertinib in Combination With Abiraterone in Metastatic Castration Resistant Prostate Cancer · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03878524Phase 1 · terminated Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial · 111 trials list this drug (47 active) | — | — | Hematopoietic and Lymphatic System Neoplasm,Hematopoietic and Lymphoid Cell Neoplasm,Malignant Solid Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01972217Phase 2 · completed Ph II Study to Evaluate Olaparib With Abiraterone in Treating Metastatic Castration Resistant Prostate Cancer. · 111 trials list this drug (47 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05405439Phase 1/Phase 2 · terminated To Evaluate the Efficacy of TQB3823 Combined With Abiraterone and Prednisone in Metastatic Castration-resistant Prostate Cancer Patientsprednisone Acetate Tablets in Patients With Metastatic Castration-resistant Prostate Cancer · 111 trials list this drug (47 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01949337Phase 3 · unknown Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer · 111 trials list this drug (47 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01995513Phase 4 · completed Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patients · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01485861Phase 1/Phase 2 · completed Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04628988Phase 1 · completed A Study of CC-90011 and Comparators in Participants With Prostate Cancer · 111 trials list this drug (47 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04179396Phase 1 · completed Study of Oral Rucaparib With Other Anticancer Agents in Metastatic Castration Resistant Prostate Cancer Patients (RAMP) · 111 trials list this drug (47 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00268476Phase 2/Phase 3 · active not recruiting Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05705700Phase 2 · withdrawn Biomarker Study of in Men With PSA Progression on Abi for CR or CS PC (Bio-STAMP) · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05376722Phase 2 · unknown A Study of Pamiparib Combined With Abiraterone Acetate in Neoadjuvant Treatment of Prostate Cancer · 111 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02789878Phase 2 · completed Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for High-Risk Prostate Cancer · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03150056Phase 1 · terminated Dose Escalation and Dose Expansion Study of GSK525762 in Combination With Androgen Deprivation Therapy in Participants With Castrate-resistant Prostate Cancer · 111 trials list this drug (47 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04087174Phase 1 · completed A Multi-centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Capivasertib (AZD5363) in Combination With Novel Agents in Patients With Metastatic Prostate Cancer · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01780220Phase 1/Phase 2 · completed Radiotherapy Plus Hormone Therapy in Biochemically-relapsing Prostate Cancer Patients Following Surgery · 111 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03295565Phase 2/Phase 3 · completed Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With Docetaxel · 111 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04862091Phase 2 · completed Comparative Study of Abiraterone Acetate Tablets (I) or ZYTIGA® in Patients With Metastatic Castration-resistant Prostate Cancer · 111 trials list this drug (47 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05188911unknown Analysis of Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated With Abiraterone: ANGELA Trial · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03896984completed Descriptive Analysis of Clinical Outcomes in Patients With Prostate Gland Cancer, Which Spreads to Other Parts of the Body, Who Were Treated First With Novel Anti-hormone Therapy Followed by a Second Line Treatment With Novel Anti-Hormone Therapy or RadIum-223 (Xofigo). · 111 trials list this drug (47 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01574937Phase 1 · completed XL-184+Abiraterone in Post-Chemo CRPC · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02867020Phase 2 · completed Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04839055Phase 1/Phase 2 · unknown The Effects of Coenzyme A Combined With Abiraterone on Patients With CRPC · 111 trials list this drug (47 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03418324Phase 2 · completed Study of TRC105 With Abiraterone and With Enzalutamide in Prostate Cancer Patients Progressing on Therapy · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02883166Phase 1 · completed Improving Bio-availability of the Expensive Oral Oncolytic Drug Abiraterone by Food Intake · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03173859Phase 2 · withdrawn Efficacy of Rotations Between Abiraterone Acetate and Apalutamide in mCRPC Patients · 111 trials list this drug (47 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02758132Phase 2 · terminated Denosumab Plus Enzalutamide, Abiraterone and Prednisone Compared to Denosumab Plus Enzalutamide Alone for Men With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastases · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01553188Phase 2 · completed AMG 386 and Abiraterone for Advanced Prostate Cancer · 111 trials list this drug (47 active) | — | — | Neoplasm,Prostate Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01741753Phase 1 · terminated BKM120+Abiraterone Acetate for Metastatic CRPC · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02254785Phase 2 · unknown Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate Cancer · 111 trials list this drug (47 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01756638Phase 2 · completed A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01828476Phase 2 · terminated Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate Cancer · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02380313Phase 1 · withdrawn Dose-Finding Study of Afuresertib Administered in Combination With Either Enzalutamide or Aibraterone · 111 trials list this drug (47 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01795703Phase 2 · completed A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer Who Have Received Docetaxel · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02049190Phase 1/Phase 2 · unknown Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01424930Phase 2 · completed A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Patients With Metastatic Castration-Resistant Prostate Cancer · 111 trials list this drug (47 active) | — | — | Prostate Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00924469Phase 2 · completed A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer · 111 trials list this drug (47 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |